HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian-Nong Cen Selected Research

Hemoglobins (Hemoglobin)

2/2009[The quantitative assay and clinical significance of JAK2V617F mutation in 131 patients with chronic myeloproliferative disorders].
9/2008[Expression of JAK2V617F and MPLW515L/K mutation in 30 suspected cases of early myeloproliferative disorders].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian-Nong Cen Research Topics

Disease

19Leukemia
08/2018 - 11/2003
9Neoplasms (Cancer)
11/2016 - 06/2002
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 06/2013
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2020 - 10/2004
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2017 - 10/2008
4Residual Neoplasm
07/2010 - 02/2005
3Chromosome Aberrations (Chromosome Abnormalities)
10/2018 - 10/2013
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 06/2010
2Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 08/2005
2Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
06/2011 - 12/2010
2Stomach Neoplasms (Stomach Cancer)
04/2010 - 05/2008
2Urinary Bladder Neoplasms (Bladder Cancer)
11/2009 - 04/2007
2Polycythemia Vera
02/2009 - 09/2008
2Carcinogenesis
05/2008 - 11/2003
1Hematologic Diseases (Blood Diseases)
12/2018
1Philadelphia Chromosome
08/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2013
1Anemia
08/2013
1Adenocarcinoma
03/2012
1Carcinoma (Carcinomatosis)
11/2009
1Transitional Cell Carcinoma
11/2009
1Myeloproliferative Disorders (Myeloproliferative Disorder)
02/2009
1Primary Myelofibrosis (Myelosclerosis)
02/2009
1Essential Thrombocythemia
09/2008
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
04/2008
1Refractory Anemia with Excess of Blasts (RAEM)
04/2008
1Acute Promyelocytic Leukemia
08/2005
1Pathologic Complete Response
11/2003

Drug/Important Bio-Agent (IBA)

9Messenger RNA (mRNA)IBA
12/2013 - 11/2003
7DNA (Deoxyribonucleic Acid)IBA
12/2018 - 08/2005
5Proteins (Proteins, Gene)FDA Link
12/2018 - 11/2003
3Complementary DNA (cDNA)IBA
07/2013 - 10/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 08/2005
3SurvivinIBA
11/2009 - 04/2007
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2008 - 08/2007
2Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2018 - 08/2005
2Biological ProductsIBA
04/2015 - 02/2008
2Transcription Factors (Transcription Factor)IBA
07/2013 - 02/2006
2Small Interfering RNA (siRNA)IBA
03/2012 - 04/2007
2Matrix Metalloproteinases (MMPs)IBA
12/2010 - 08/2007
2Immunoglobulins (Immunoglobulin)IBA
07/2010 - 10/2008
2Monoclonal AntibodiesIBA
06/2010 - 06/2010
2MethyltransferasesIBA
04/2010 - 05/2008
2Hemoglobins (Hemoglobin)IBA
02/2009 - 09/2008
2Telomerase (Telomerase Reverse Transcriptase)IBA
04/2008 - 11/2003
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2008 - 08/2005
2Protein Isoforms (Isoforms)IBA
02/2006 - 12/2005
1isocitrate dehydrogenase (NADP+)IBA
12/2018
1hydrogen sulfite (bisulfite)IBA
12/2018
1Imatinib Mesylate (Gleevec)FDA Link
10/2018
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
08/2018
1DecitabineFDA Link
08/2018
1triptolideIBA
11/2016
1Arsenic Trioxide (Trisenox)FDA Link
11/2016
1Indicators and Reagents (Reagents)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Etoposide (VP 16)FDA LinkGeneric
01/2016
1HLA-DR Antigens (HLA-DR)IBA
04/2015
1Phosphotransferases (Kinase)IBA
08/2014
1Uracil-DNA GlycosidaseIBA
08/2014
1Tyrosine Kinase InhibitorsIBA
08/2014
1ChromatinIBA
12/2013
1CD34 Antigens (CD34 Antigen)IBA
10/2013
13-Phosphoinositide-Dependent Protein KinasesIBA
10/2013
1Beclin-1IBA
08/2013
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
07/2013
1Co-Repressor ProteinsIBA
07/2013
1CCAAT-Enhancer-Binding ProteinsIBA
07/2013
1calcium phosphateIBA
06/2013
1LipofectamineIBA
03/2012
1Insulin-Like Growth Factor Binding ProteinsIBA
02/2012
1Simvastatin (Zocor)FDA LinkGeneric
06/2011
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2010
1Tissue Inhibitor of Metalloproteinase-2IBA
12/2010
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2010
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
07/2010
1beta-Galactosidase (Lactaid)IBA
11/2009
1Cytochrome P-450 CYP3AIBA
07/2009
1RNA (Ribonucleic Acid)IBA
02/2009
1Transcription Factor 3IBA
05/2008
1Core Binding Factor Alpha 3 SubunitIBA
05/2008
1CytokinesIBA
02/2008
1alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA
08/2007
1Gadolinium DTPA (Magnevist)FDA Link
04/2007
1Contrast MediaIBA
04/2007
1Mitomycin (Mitomycin-C)FDA LinkGeneric
04/2007
1Cyclin A1IBA
02/2006
1Trypan BlueFDA Link
02/2006
1tributyrinIBA
10/2005
1ImmunosorbentsIBA
11/2003
1EnzymesIBA
11/2003
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2002
1Aldehyde DehydrogenaseIBA
06/2002

Therapy/Procedure

3Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2007 - 02/2005
2Hematopoietic Stem Cell Transplantation
08/2020 - 08/2007
2Therapeutics
10/2018 - 11/2016
1Stem Cell Transplantation
08/2007
1Subcutaneous Injections
08/2007